发明名称 |
NOVEL COMPOUND HAVING ABILITY TO INHIBIT 11B-HSD1 ENZYME OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, METHOD FOR PRODUCING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT |
摘要 |
The present invention relates to a novel compound or a pharmaceutically acceptable salt thereof inhibiting 11β-HSD1 enzyme activity, a preparation method of the same, and a pharmaceutical composition comprising the same as an active ingredient. Since the compound of the present invention selectively inhibits the activity of 11β-HSD1 (11β-Hydroxysteroid dehydrogenase type 1), the compound of the invention can be effectively used as a therapeutic agent for the treatment of diseases caused by the over-activation of 11β-HSD1 such as non-insulin dependent type II diabetes, insulin resistance, obesity, lipid disorder, metabolic syndrome, and other diseases or condition mediated by the excessive activity of glucocorticoid. |
申请公布号 |
US2015210635(A1) |
申请公布日期 |
2015.07.30 |
申请号 |
US201314409414 |
申请日期 |
2013.06.04 |
申请人 |
AHN-GOOK PHARMACEUTICAL CO., LTD. ;BAMICHEM Co., Ltd. ;INCHEON UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION |
发明人 |
Ahn Soon Kil;Auh Jin;Choi Nam Song;Han Chang Kyun;Kim Tae-Jeong;Pae Kamsa;Shin Young June;Han Dong-Oh;Han Cheol Kyu |
分类号 |
C07C311/21;C07C311/19 |
主分类号 |
C07C311/21 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
Seoul KR |